Kiromic Biopharma, Inc.
KRBPDelisted Nov 20, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001792581
Kiromic Biopharma, Inc. was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Aug 26, 2024; no institution reported holding it in 13F filings for Q3 2023; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in Kiromic Biopharma, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- −4 vs. Q3 2022
- Shares held
- 805.6K
- +483.5K (+150.1%) vs. Q3 2022
- Total value
- $145.5K
- +$55.2K (+61.1%) vs. Q3 2022
- New holders
- 2
- 3 more added
- Sold out
- 6
- 1 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KRBP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 5 | $6.13K |
| Q1 2023 | 7 | $78.2K |
| Q4 2022 | 12 | $145.5K |
| Q3 2022 | 16 | $90.3K |
| Q2 2022 | 17 | $200.0K |
| Q1 2022 | 20 | $1.73M |
| Q4 2021 | 21 | $3.82M |
| Q3 2021 | 23 | $7.49M |
| Q2 2021 | 16 | $11.9M |
| Q1 2021 | 13 | $3.34M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Kiromic Biopharma, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 77 | $14 | 0.00% | +2+2.7% | Added |
| Group One Trading, L.P. | 192 | $35 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 1,206 | $218 | 0.00% | +6+0.5% | Added |
| The PNC Financial Services Group, Inc. | 4,000 | $724 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,675 | $1.00K | 0.00% | −199−4.1% | Reduced |
| WealthTrust Axiom LLC | 10,000 | $1.81K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 16,976 | $3.06K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 31,810 | $6.00K | 0.00% | +31,810 | New |
| UBS Group AG | 38,757 | $6.98K | 0.00% | +20,247+109.4% | Added |
| Geode Capital Management, LLC | 40,962 | $7.00K | 0.00% | 00.0% | Unchanged |
| Zeke Capital Advisors, LLC | 107,000 | $19.3K | 0.00% | 00.0% | Unchanged |
| Sabby Management, LLC | 549,944 | $99.4K | 0.27% | +549,944 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −39,865−100.0% | Sold out |
| Redmond Asset Management, LLC | 0 | $0 | 0.00% | −41,758−100.0% | Sold out |
| StoneX Group Inc. | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −11,052−100.0% | Sold out |
| Cetera Advisor Networks LLC | 0 | $0 | 0.00% | −10,509−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |